Literature DB >> 30359765

Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation.

Eri Toda Kato1, Shinya Goto2, Robert P Giugliano3.   

Abstract

Atrial fibrillation (AF) is an age-related arrhythmia, particularly affecting elderly patients. The ultimate goals in the treatment of AF are to improve prognosis and quality of life. Anticoagulants are effective for stroke prevention in AF patients, however, managing anticoagulation in elderly patients is especially challenging; requiring a comprehensive assessment of the patient and deep understanding of available therapies and doses to maximize the net benefit. This review summarizes available evidence on the efficacy and safety of anticoagulation therapy, and provides contemporary updates on the management of elderly patients with AF.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Bleeding; Elderly; Stroke

Mesh：

Substances：

Year:  2018        PMID： 30359765     DOI： 10.1016/j.arr.2018.10.006

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN： 1568-1637            Impact factor:   10.895


  8 in total

Review 1.  Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.

Authors:  Stefano Ballestri; Elisa Romagnoli; Dimitriy Arioli; Valeria Coluccio; Alessandra Marrazzo; Afroditi Athanasiou; Maria Di Girolamo; Cinzia Cappi; Marco Marietta; Mariano Capitelli
Journal:  Adv Ther       Date:  2022-10-16       Impact factor: 4.070

2.  Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel.

Authors:  Nicola Mumoli; Claudia Amellone; Gianfranco Antonelli; Giuseppe Augello; Cosima Cloro; Alberto D'Alleva; Leonardo Di Ascenzo; Egidio Imbalzano; Renato Masala; Graziano Riccioni; Emanuele Romeo; Luca Rossi; Giosuè Santoro; Edoardo Sciatti; Antonio Tondo; Elisabetta Toso; Elio Venturini; Enrico Vizzardi; Giosuè Mascioli
Journal:  CJC Open       Date:  2020-07-23

Review 3.  Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation.

Authors:  Gianluca Botto; Pietro Ameri; Manuel Cappellari; Francesco Dentali; Nicola Ferri; Iris Parrini; Italo Porto; Alessandro Squizzato; Giuseppe Camporese
Journal:  Adv Ther       Date:  2021-05-21       Impact factor: 3.845

4.  Antithrombotic Therapy in Spinal Surgery Does Not Impact Patient Safety-A Single Center Cohort Study.

Authors:  Mohammed Banat; Johannes Wach; Abdallah Salemdawod; Gregor Bara; Ehab Shabo; Jasmin E Scorzin; Martin Müller; Hartmut Vatter; Lars Eichhorn
Journal:  Front Surg       Date:  2022-01-26

Review 5.  Practical considerations for colorectal cancer screening in older adults.

Authors:  Dana Gornick; Anusri Kadakuntla; Alexa Trovato; Rebecca Stetzer; Micheal Tadros
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

6.  Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation.

Authors:  Alexandros A Polymeris; Kosmas Macha; Maurizio Paciaroni; Duncan Wilson; Masatoshi Koga; Manuel Cappellari; Sabine Schaedelin; Annaelle Zietz; Nils Peters; David J Seiffge; David Haupenthal; Luise Gassmann; Gian Marco De Marchis; Ruihao Wang; Henrik Gensicke; Svenja Stoll; Sebastian Thilemann; Nikolaos S Avramiotis; Bruno Bonetti; Georgios Tsivgoulis; Gareth Ambler; Andrea Alberti; Sohei Yoshimura; Martin M Brown; Masayuki Shiozawa; Gregory Y H Lip; Michele Venti; Monica Acciarresi; Kanta Tanaka; Maria Giulia Mosconi; Masahito Takagi; Rolf H Jäger; Keith Muir; Manabu Inoue; Stefan Schwab; Leo H Bonati; Philippe A Lyrer; Kazunori Toyoda; Valeria Caso; David J Werring; Bernd Kallmünzer; Stefan T Engelter
Journal:  Ann Neurol       Date:  2021-11-29       Impact factor: 11.274

7.  Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study.

Authors:  I-Chih Chen; Wei-Ting Chang; Po-Chao Hsu; Ya-Lan Yeh; Syuan Zheng; Yuan-Chi Huang; Chih-Hsien Lin; Liang-Miin Tsai; Li-Jen Lin; Ping-Yen Liu; Yen-Wen Liu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

8.  Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study.

Authors:  Hirotsugu Atarashi; Shinichiro Uchiyama; Hiroshi Inoue; Takanari Kitazono; Takeshi Yamashita; Wataru Shimizu; Takanori Ikeda; Masahiro Kamouchi; Koichi Kaikita; Koji Fukuda; Hideki Origasa; Hiroaki Shimokawa
Journal:  Heart Vessels       Date:  2021-03-16       Impact factor: 2.037
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.